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Abstract
We report the preparation of novel magnetic field-responsive tissue substitutes based on
biocompatible multi-domain magnetic particles dispersed in a fibrin–agarose biopolymer
scaffold. We characterized our biomaterials with several experimental techniques. First we
analyzed their microstructure and found that it was strongly affected by the presence of
magnetic particles, especially when a magnetic field was applied at the start of polymer
gelation. In these samples we observed parallel stripes consisting of closely packed fibers,
separated by more isotropic net-like spaces. We then studied the viability of oral mucosa
fibroblasts in the magnetic scaffolds and found no significant differences compared to posi-
tive control samples. Finally, we analyzed the magnetic and mechanical properties of the
tissue substitutes. Differences in microstructural patterns of the tissue substitutes correlated
with their macroscopic mechanical properties. We also found that the mechanical properties
of our magnetic tissue substitutes could be reversibly tuned by noncontact magnetic forces.
This unique advantage with respect to other biomaterials could be used to match the
mechanical properties of the tissue substitutes to those of potential target tissues in tissue
engineering applications.
Introduction
Biomaterials intended for applications in regenerative medicine must imitate the histological
structure of natural tissues. They should thus meet a number of requirements, including
biocompatibility [1–4]. Various scaffold materials have been tested, including both naturally-
derived and synthetic polymers. Although natural materials provide a physiological environ-
ment for cell adhesion and proliferation, they have several disadvantages, such as their subopti-
mal mechanical properties [5–8]. Synthetic materials are extensively used because of their easy
molding characteristics, relatively easy production and their ability to control dissolution and
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degradation [9]. The main drawback of synthetic materials is that they do not have natural
sites for cell adhesion [10].
One alternative to choosing between natural or synthetic materials is to use them in combi-
nation [11]. For example, several authors have very recently used magnetic nanoparticles in
combination with polymers to prepare innovative magnetic scaffolds for tissue substitutes [12–
29]. These magnetic scaffolds have several advantages. First, the ferromagnetic behavior of the
magnetic scaffolds allows visualization and in-vivo follow-up by magnetic resonance imaging
[28]. Second, in-vitro studies indicate that magnetic nanoparticles in the scaffolds do not
compromise cell adhesion, proliferation or differentiation [12,13,25]. Furthermore, the main
advantage of novel magnetic scaffolds is that they acquire a magnetic moment when an exter-
nal magnetic field is applied, i.e. they act as magnets, attracting functionalized magnetic nano-
particles injected close to them [13,21,28]. This represents a promising strategy to guide and
accumulate growth factors, drugs and cells previously attached to the injected magnetic
nanoparticles.
To the best of our knowledge, all magnetic scaffolds described to date are based on the use
of magnetic particles measuring on the order of 10 nm in diameter. Magnetic particles of this
size are single-domain in terms of their magnetic behavior. Moreover, because of their small
size the magnetic energy of interaction between particles is weak compared to the energy of
Brownian motion [30]. As a result, even for strong applied magnetic fields, Brownian motion
dominates over the magnetic forces, and the mechanical properties of the scaffolds cannot be
controlled by noncontact magnetic forces. The situation is radically different for magnetic par-
ticles larger than approximately 50–100 nm. Particles of this size are multi-domain in terms of
their magnetic behavior. This means that there is no magnetic interaction between them prior
to the application of a magnetic field. In addition, because of their relatively large size, Brown-
ian motion is negligible compared to magnetic interaction in the presence of moderate mag-
netic fields [30], which makes it theoretically possible to control, via noncontact magnetic
forces, the mechanical properties of biomaterials that contain the particles.
The main aim of the present study was to generate magnetic biomaterials whose mechanical
properties can be controlled by noncontact magnetic forces. To this end we used a mixture of
fibrin and agarose as a polymer matrix. We chose this combination because fibrin is a natural
polymer used frequently in tissue engineering. The main drawback of fibrin hydrogels lies in
their suboptimal biomechanical properties, which fortunately can be enhanced by combining
them with agarose [31]. We previously showed that these fibrin–agarose biomaterials have bet-
ter biomechanical and structural properties than fibrin alone [31–33]. In addition, we recently
demonstrated that the biomechanical properties of fibrin–agarose hydrogels reproduce the
properties of several native soft human tissues [31]. Fibrin–agarose biomaterials have been
used successfully to generate bioengineered substitutes of several human tissues such as the
cornea, oral mucosa, skin and peripheral nerves, and were shown to be effective in vivo [32–
34]. In the present study we demonstrate that the incorporation of magnetic particles gives rise
to bioengineered oral mucosa tissue substitutes with a tunable, reversible mechanical response.
In tissue engineering applications this versatility should make it possible to adjust the mechani-
cal properties of the artificial tissue substitutes with precision, in order to match the properties
of the target tissue at the site of implantation.
Materials and Methods
Ethics statement
This study was approved by the Ethics Committee of the University of Granada, Granada,
Spain. Each tissue donor signed an informed consent form for this study.
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Establishment of primary cultures of oral mucosa fibroblasts
Ten normal human oral mucosa biopsies with an average volume of 8 mm3 were obtained
from healthy donors at the School of Dental Sciences of the University of Granada. To obtain
primary cultures of human oral mucosa fibroblasts, tissues were enzymatically de-epithelized
and the lamina propria was digested in a mixture of Dulbecco’s Modified Eagle’s Medium
(DMEM) and 2 mg/mL Clostridium histolyticum collagenase I (Gibco BRL Life Technologies,
Karlsruhe, Germany). Detached fibroblasts were collected by centrifugation and expanded in
culture fiasks containing DMEM supplemented with 10% fetal calf serum (FCS) and 1% antibi-
otic–antimycotic solution (final concentration 100 U/mL penicillin G, 0.10 mg/mL streptomy-
cin and 0.25 μg/mL amphotericin B) (all from Sigma-Aldrich, Steinheim, Germany). Cells
were incubated at 37°C in 5% carbon dioxide under standard culture conditions. The medium
was changed every 3 days, and the cells were subcultured in a solution of 0.5 g/L trypsin and
0.2 g/L EDTA at 37°C for 10 min. For all experiments we used cells from the first 3 passages of
these human oral mucosa fibroblast cell cultures.
Preparation of the biomaterials (three-dimensional tissue substitutes)
For the magnetic phase we used MagP-OH particles (Nanomyp, Granada, Spain). According
to the manufacturer, MagP-OH particles consist of biocompatible nanoparticles with a mean
diameter of 115 nm, comprising a single magnetic core of magnetite (γ-Fe3O4) coated by a
polymer layer of methyl methacrylate-co-hydroxyl ethyl methacrylate-co-ethylene glycol
dimethacrylate. MagP-OH particles were supplied as an aqueous suspension stabilized with
surfactants, and were treated before use with 5 washing cycles (centrifugation at 15000 g for
30 min, supernatant discarded, ultrapure water added, particles redispersed) to remove the sur-
factant. We then replaced the water carrier with 70% ethanol and left the nanoparticles in this
solution for 12 h for sterilization. Finally the ethanol was removed, and the nanoparticles were
suspended in DMEM.
For the continuous matrix we used a mixture of fibrin and agarose as the biopolymer. The
target tissue was human oral mucosa, thus, seeding with human oral mucosa fibroblasts was
required. To prepare the magnetic tissue substitutes we used a variation of a previous method
for fibrin–agarose nonmagnetic scaffolds [32]. Briefly, we used 3.8 mL human plasma obtained
from blood donors (provided by the Granada Biobank of the Andalusian Regional Govern-
ment), to which we added 1,000,000 oral mucosa fibroblasts resuspended in 0.625 mL DMEM,
together with 75 μL of a solution of tranexamic acid at a concentration of 0.1 g/mL. The
final concentration of tranexamic acid in the biomaterial was 1.5 mg/mL. This acid is an anti-
fibrinolytic agent that prevents degradation of the scaffold. We then added the appropriate
amounts of a concentrated suspension of MagP-OH particles in DMEM to a final concentra-
tion of approximately 2 mL of particles per 100 mL of mixture. Subsequently, 0.25 mL of a mix-
ture of type VII agarose (a polysaccharide polymer material with a molecular weight of approx.
120,000 g/mol, supplied by Sigma-Aldrich Química SA, Madrid, Spain) in phosphate-buffered
saline (PBS) (0.02 g/mL concentration) was added to the mixture to a final agarose concentra-
tion of 0.1%. Then 0.25 mL of 2% CaCl2 was added to the mixture to activate the fibrin poly-
merization process. The final volume of the mixture was 5 mL, which contained 200,000 cells
per mL of mixture. This cell density is on the same order of magnitude as (or higher than) the
number of cells validated for fibrin–agarose gels in previous studies [32–34].
The mixtures were seeded on petri dishes and kept at 37°C for 2 h until gelation was com-
plete. We applied a vertical magnetic field to the mixtures during the first 5 min of gelation
with a coil connected to a DC power supply. We subjected different samples to different field
strengths ranging from 0 to 48 kA/m in intensity (0, 16, 32 or 48 kA/m). After 2 h we added to
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the gels (tissue substitutes) DMEMmedium supplemented with 10 vol% FCS and 1 vol% anti-
biotic–antimycotic solution, and incubated the cultures for 24 h at 37°C in the culture dishes.
For comparison we also prepared nonmagnetic tissue substitutes (control samples) with
the same procedure as described above, except for the addition of magnetic particles. We also
subjected these samples to applied magnetic fields of different intensity during gelation (0,
16, 32 or 48 kA/m) in order to analyze the effect of the magnetic field on the biological constit-
uents in the tissue substitutes. To analyze the effect of the magnetic MagP-OH particles on the
substitute properties more precisely, we also prepared a nanoparticle control sample (Ctrl-NP)
which contained nonmagnetic polymer particles. These particles (PolymP-C, NanoMyP) were
uniformly spherical and similar in diameter (approximately 130 nm) to MagP-OH particles,
but lacked magnetic properties. Their chemical composition was similar to the polymer layer
constituting the shell of MagP-OH, since they are made from the same polymers with OH
functionalization. We prepared Ctrl-NP tissue substitutes with the same procedure as
described above for magnetic tissue substitutes, but with PolymP-C particles instead of Mag-
P-OH particles. Prior to use we sterilized the PolymP-C particles by immersion for 12 h in 70%
ethanol, followed by ethanol removal and dispersion in DMEM.
In all, we prepared oral mucosa substitutes with 9 different protocols (Table 1). The density
of all substitutes was approximately 1.1 g/mL.
Structural analysis
After 24 h of cell culture, we fixed the oral mucosa tissue substitutes in formalin, embedded
them in paraffin, and cut them in 5-μm-thick sections. After deparaffination and hematoxylin–
eosin staining, we analyzed structural features in the biomaterial sections by light microscopy.
For scanning electron microscopy (SEM), samples were fixed in 2.5% glutaraldehyde and post-
fixed in 1% osmium tetroxide for 90 min. After fixation, the samples were dehydrated in
increasing concentrations of acetone (30%, 50%, 70%, 95% and 100%), critical point-dried,
mounted on aluminum stubs and sputter-coated with gold according to routine procedures.
Cell viability analysis
We evaluated cell viability by measuring intracellular esterase activity, and by examining the
integrity of the plasma and nuclear membranes with a fluorescence-based method using the
Live/Dead commercial kit (Life Technologies, Carlsbad, CA, USA). This method uses calcein-
Table 1. Summary of the different oral mucosa substitutes prepared for this study.
Magnetic ﬁeld strength during gelation (kA/m) Approx. concentration of particles (volume %) Type of particles Sample name
0 0 — Ctrl-MF0
0 2 MagP-OH ª M-MF0
0 2 PolymP-C b Ctrl-NP
16 0 — Ctrl-MF16
16 2 MagP-OH ª M-MF16
32 0 — Ctrl-MF32
32 2 MagP-OH ª M-MF32
48 0 — Ctrl-MF48
48 2 MagP-OH ª M-MF48
ª Magnetite (core)/polymer (shell) MagP-OH particles (Nanomyp).
b Nonmagnetic polymer PolymP-C particles (Nanomyp).
doi:10.1371/journal.pone.0133878.t001
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AM, which is metabolically modified by living cells to a green pigment, and ethidium homodi-
mer-1, which stains the nuclei of dead cells red. We obtained aliquots of 3 mm in diameter of
all biomaterial samples after 24 h of cell culture, discarded the supernatants and washed the ali-
quots with PBS, then cut them into very thin films, incubated them with the Live/Dead solution
for 15 min as indicated by the manufacturer, and washed them with PBS. We then observed
the samples by fluorescence microscopy and processed the images with ImageJ software to
quantify the number of live (green) and dead cells (red).
We also evaluated cell death as nuclear membrane integrity by quantifying the DNA
released to the culture medium. We obtained supernatants of each sample and diluted 10-μL
aliquots in distilled water free of nuclease (Ambion-Life Technologies, Austin, TX, USA). The
DNA in the medium was quantified spectrophotometrically (SmartSpec Plus, Bio-Rad, Hercu-
les, CA, USA) at wavelengths in the range of 260–280 nm.
The mean values ± standard deviations of 8 independent experiments are reported here for
each experimental group and each analysis. The Kruskal–Wallis test was used to identify statis-
tical differences among study groups, and the Mann–Whitney test was used to identify signifi-
cant differences between two groups. Values of p less than 0.05 were considered statistically
significant in two-tailed tests.
Magnetic properties
Wemeasured the magnetization (M) of dry MagP-OH particles at 37°C as a function of the
magnetic field strength (H) in a Squid Quantum Design MPMS XL magnetometer. In addition,
we obtained the magnetization curve of soaked tissue substitutes 24 h after cell culture. The
magnetization curves reported here correspond to the mean of 3 independent measurements.
Mechanical properties
We characterized the mechanical properties of the tissue substitutes (summarized in Table 1)
with a Haake MARS III (Thermo Fisher Scientific, Waltham, MA, USA) controlled stress rhe-
ometer at 37°C. The measuring system geometry was a 3.5 cm diameter parallel plate set with
rough surfaces to avoid wall slip.
We obtained measurements as follows. First we placed the sample in the rheometer measur-
ing system and squeezed it by lowering the rotating plate until a normal force of 5 N was
reached. The rheometer gap at which this force was seen varied slightly depending on the sam-
ple, but was in all cases approximately 300 μm. We obtained measurements both in the absence
and presence of a magnetic field. For this purpose we used a coil connected to a DC power sup-
ply, with the axis of the coil aligned with the axis of the parallel plate measuring system. For
measurements obtained during magnetic field application, we applied the magnetic field from
1 min before measurement was started until the measurement was recorded. We used two
types of rheological test: oscillatory shear at a fixed frequency, and steady-state shear strain
ramps, as described below.
Oscillatory shear in fixed frequency–variable amplitude sweeps. For these tests, we
subjected the samples to sinusoidal shear strains at a fixed frequency (1 Hz) and increasing
amplitude (logarithmically spaced in the 0.05–1.0 range), and measured the corresponding
oscillatory shear stresses. Each frequency–amplitude pair was maintained during 5 oscillatory
cycles, although we only used data for the last 3 cycles to rule out transients. These measure-
ments were used to calculate the elastic modulus G0 as a function of shear strain.
Steady state shear strain ramps. In these tests the samples were subjected to a constant
shear strain for 10 s and the resulting shear stress was measured. Measurements were repeated
at increasing (linearly spaced) shear strain values until the nonlinear regime was reached.
Magnetic Field-Responsive Biomaterials
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We carried out each type of measurement for 3 different aliquots of each sample. For each
aliquot we carried out at least 3 repetitions to record a minimum of 9 values per data point.
First we recorded measurements atH = 0 kA/m, then atH = 9 kA/m,H = 17 kA/m, and H = 26
kA/m. Then we returned to H = 0 kA/m and repeated this cycle at least twice for each aliquot.
The results obtained for each sample and experimental condition showed no statistically signif-
icant differences.
Results and Discussion
Structural analysis
Macroscopically, the magnetic tissue substitutes (M-MF0, M-MF16, M-MF32, M-MF48) were
similar in appearance to nonmagnetic tissue substitutes (Ctrl-MF0, Ctrl-MF16, Ctrl-MF32,
Ctrl-MF48, Ctrl-NP), although the former were darker than control tissue substitutes without
particles (Ctrl-MF0 to Ctrl-MF48), which were whitish and semitransparent, and control tissue
substitutes with nonmagnetic particles (Ctrl-NP), which were bright white. Magnetic tissue
substitutes were attracted by a magnet, as seen in S1 Video.
For the control group without particles gelled in the absence of an applied magnetic field
(Ctrl-MF0), microscopic analysis showed normally-shaped fusiform and star-shaped cells
(Fig 1A). The cells were distributed throughout the fibrin–agarose matrix in a normal, net-
like appearance. There were no cell–cell contacts, but cell–matrix contacts were evident, as
expected in a connective tissue substitute. Cells in the control groups without particles gelled in
the presence of an applied magnetic field were similar in appearance (not shown). In samples
containing particles, we found that in the magnetic tissue substitute gelled in the absence of an
applied magnetic field (M-MF0), as well as the control tissue substitute with nonmagnetic poly-
mer particles (Ctrl-NP), the particles were distributed randomly in an isotropic, homogeneous
Fig 1. Microscopic images of tissue substitutes. 1a-1d: Light microscopy. 1e-1h: Scanning electron micrographs with individual cells shown in the insets.
1a and 1e: control (nonmagnetic) samples gelled in the absence of a magnetic field (Ctrl-MF0). 1b and 1f: control (nonmagnetic) samples with nonmagnetic
polymer particles (Ctrl-NP). 1c and 1g: magnetic samples gelled in the absence of a magnetic field (M-MF0). 1d and 1h: magnetic samples gelled during
application of a magnetic field (32 kA/m in 1d, and 48 kA/m in 1h). A few of the cells are marked with arrows in Fig 1a to 1d. Scale bars: Fig 1a-1d, 100 μm; Fig
1e-1h, 50 μm including insets, except for insets in Fig 1e and 1f, 20 μm.
doi:10.1371/journal.pone.0133878.g001
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pattern (Fig 1B and 1C). In contrast, magnetic samples gelled in the presence of a magnetic field
(M-MF16, M-MF32, andM-MF48) presented a microscopic pattern consisting of filament-like
structures aligned in the same direction, regardless of the intensity of the applied field (Fig 1D).
Scanning electron micrographs showed that control samples without particles (Ctrl-MF0 to
Ctrl-MF48) presented an isotropic, homogeneous network of randomly aligned fibrin fibers
(see Ctrl-MF0, Fig 1E). Application of a magnetic field during gelation in these control samples
did not lead to significant changes in their microscopic morphology. Samples Ctrl-MF16 to
Ctrl-MF48 (not shown) were similar in appearance to Ctrl-MF0. The presence of magnetic or
nonmagnetic nanoparticles induced changes in the fibrillar pattern even in the absence of a
magnetic field during gelation. Although the tissue substitutes retained their homogeneous
morphology, some particles and particle aggregates were homogeneously distributed through-
out the fibrin network, disrupting its mesoscopic ordering (Fig 1F and 1G). When a magnetic
field was applied during gelation in magnetic samples, the fibrin network presented an aniso-
tropic pattern (with one direction predominating) characterized by thick stripes containing
closely packed fibrin fibers aligned and braided in the direction of the stripes, and isotropic
net-like spaces between the stripes, with fewer fibers (Fig 1H, M-MF48). The stronger the field
applied during gelation, the more evident the thick stripes. At the highest field strength (sample
M-MF48) these stripes were 3.2 ± 1.3 μm in diameter. The aligned distribution of fibers associ-
ated with the formation of stripes might induce contact guidance of cells.
The reasons for the striped appearance of magnetic tissue substitutes gelled during exposure
to a magnetic field merit consideration. To prepare samples M-MF16, M-MF32 and M-MF48
we applied a magnetic field from the beginning of gelation for 5 min. Application of a magnetic
field to multi-domain magnetic particles (such as MagP-OH nanoparticles) induces the
appearance of a net magnetic moment aligned with the field direction in each particle (i.e.,
polarization of the particle). This results in magnetostatic forces of attraction between particles,
and when particles are free to move (i.e., when they are dispersed in a liquid-like carrier), they
migrate and aggregate into chain-like structures aligned with the field direction, in order to
minimize the energy of the system [30]. Since the speed of particle polarization and migration
is on the order of milliseconds [30], it is reasonable to assume that fibrin gelation in samples
M-MF16, M-MF32 and M-MF48 took place, from the first few seconds, in the presence of
MagP-OH particle structures distributed throughout the biomaterial and oriented in the direc-
tion of the applied field. Our hypothesis for the formation of the thick fibrin stripes we
observed is that these chain-like particle structures acted as condensation fibers for the braid of
biopolymer fibers, so that only some residual fibers gelled outside the stripes, giving rise to the
microscopic pattern seen in samples M-MF16, M-MF32 and M-MF48 (Fig 1H). This hypothe-
sis is also supported by the fact that no MagP-OH nanoparticles were observed in Fig 1H, from
which we infer that all the particles were trapped in the fibrin stripes.
In this connection, we note that according to Tampieri et al. [23], in scaffolds made of mag-
netic particles and hydroxyapatite–collagen composites, the magnetic phase acts as a cross-link-
ing agent for the collagen. Furthermore, Panseri et al. [21] showed that the fibril network in
scaffolds made of magnetic particles and hydroxyapatite–collagen composites was influenced by
the preparation method. When the particles were already dispersed in the solution before poly-
mer gelation started (as in the engineered biomaterials described here), the magnetic phase was
completely amalgamated and homogeneously distributed throughout the fibril network. On the
other hand, when the magnetic scaffold was obtained by soaking a previously prepared nonmag-
netic scaffold in a ferrofluid, the nanoparticles were simply adsorbed onto the surface of the colla-
gen fibers. Thanikaivelan et al. [35] found that the collagen fibers were considerably stabilized
when superparamagnetic Fe2O3 nanoparticles suspended in a liquid carrier were used upon
application of a magnetic field of approximately 2,000 Oe (approximately 160 kA/m).
Magnetic Field-Responsive Biomaterials
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Cell viability analysis
Representative fluorescence microscopy images from the viability assays are shown in Fig 2.
From these images we obtained the number of viable cells, which remained above 90% in all
experimental groups, with no significant differences (p>0.05) among groups (Fig 2).
Similarly, we observed no significant difference (p>0.05) in the amount of free DNA
among the different experimental groups (Fig 3).
According to results in Figs 2 and 3, cell viability was high in both magnetic and the non-
magnetic control tissue substitutes. We interpret this to mean that magnetic and nonmagnetic
nanoparticles did not alter cell viability, and that magnetic tissue substitutes are likely to be safe
for use in vivo, in agreement with previous results [12,13].
Magnetic properties
The magnetization curve of MagP-OH particles (not shown) displayed typical soft ferromag-
netic features, with a saturation magnetization of 161 ± 7 kA/m, obtained by fitting the experi-
mental data to the Fröhlich–Kennely law [36]. Similarly, magnetic tissue substitutes showed
soft ferromagnetic features, although with much lower saturation magnetization values (Fig 4).
Differences in the saturation magnetization values between different magnetic tissue substi-
tutes were most likely due mainly to their different MagP-OH particle content. In fact, the con-
centration of MagP-OH particles in the tissue substitutes can be estimated by comparing their
saturation magnetization (obtained by fitting the experimental data to the Fröhlich–Kennely
law) to the saturation magnetization of MagP-OH powder, on the basis of the mixing law
[37]. From the best fits to the mixing law, we obtained the following values for MagP-OH parti-
cle volume concentration (ϕ), M-MF0: 2.9 ± 0.3 vol%; M-MF16: 2.5 ± 0.3 vol%; M-MF32:
1.66 ± 0.16 vol%; M-MF48: 2.22 ± 0.22 vol%. Note that as expected, nonmagnetic control tissue
substitutes did not show any ferromagnetic behavior.
Fig 2. Cell viability tests. Fluorescence microscopy images (scale bar: 100 μm) representative of each experimental group. Live cells are stained green,
and dead cells red. The graph shows the mean values ± standard deviations for live cells from 8 independent experiments for each experimental group. Ctrl-
MF0: control (nonmagnetic) tissue substitute without particles, gelled in the absence of a magnetic field; Ctrl-NP: control (nonmagnetic) tissue substitute with
nonmagnetic polymer particles; M-MF0: magnetic tissue substitute gelled in the absence of a magnetic field; M-MF16, M-MF32 and M-MF48: magnetic tissue
substitutes gelled during application of a 16 kA m-1, 32 kA m-1 or 48 kA m-1 field, respectively.
doi:10.1371/journal.pone.0133878.g002
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Mechanical properties
In the absence of a magnetic field, we observed much higher values for elastic modulus G0 (up
to 4 times as high) and shear stress (up to 5 times as high for a given value of shear strain) in
the oral mucosa tissue substitutes that contained either magnetic or nonmagnetic particles
compared to tissue substitutes without particles (Fig 5).
The differences between the values for nonmagnetic control tissue substitutes without parti-
cles were small. On the other hand, tissue substitutes containing particles differed in G0 by as
much as 40%, whereas shear stress was approximately similar in all samples with the exception
of magnetic samples gelled in the absence of an applied field (M-MF0), and nonmagnetic con-
trol samples containing polymer particles (Ctrl-NP) at the highest strain values. Regarding the
correlation between G0 and shear strain amplitude, we found that in all cases G0 showed an ini-
tial pseudoplateau at low amplitude, followed by a decrease at medium and high amplitudes.
Fig 3. Quantification of DNA release. Integrity of the nuclear membrane was studied by quantifying the DNA released in the culture medium. The graph
shows the mean values ± standard deviations of 8 independent experiments for each experimental group. Ctrl-MF0: control (nonmagnetic) tissue substitute
without particles, gelled in the absence of a magnetic field; Ctrl-NP: control (nonmagnetic) tissue substitute with nonmagnetic polymer particles; M-MF0:
magnetic tissue substitute gelled in the absence of a magnetic field; M-MF16, M-MF32 and M-MF48: magnetic tissue substitutes gelled during application of
a 16 kA m-1, 32 kA m-1 or 48 kA m-1 field, respectively.
doi:10.1371/journal.pone.0133878.g003
Magnetic Field-Responsive Biomaterials
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The initial pseudoplateau determines the so-called viscoelastic linear region (VLR) and the rest
of the curve is referred to as the nonlinear viscoelastic region. Usually, the value of G0 pertain-
ing to the VLR is considered an indicator of the strength of the material: the higher the G0, the
stronger the material. With respect to the shape of the curves of shear stress vs. shear strain, we
observed an initial linear portion at low strain values, where stress was proportional to strain.
The proportionality constant is known as the shear modulus, G. At higher values of shear strain
linearity was lost, and stress increased more slowly. Apart from the higher values of G for sam-
ples containing either magnetic or nonmagnetic particles compared to nonmagnetic control
samples without particles (up to 3 times as high), we note that linearity was maintained up to
much higher strain values in the former samples, especially magnetic tissue substitutes gelled
during field application, compared to the nonmagnetic samples (Fig 5B). Note that G is also
usually considered a measure of the strength of a material.
Fig 4. Magnetization curves of magnetic tissue substitutes. Filled squares: tissue substitute gelled in the
absence of a magnetic field (M-MF0); open circles: tissue substitute gelled during application of a 16 kA m-1
field (M-MF16); open triangles: tissue substitute gelled during application of a 32 kA m-1 field (M-MF32); filled
triangles: tissue substitute gelled during application of a 48 kA m-1 field (M-MF48). Values for saturation
magnetization (kA/m) were obtained according to the Fröhlich–Kennely law [36]: M-MF0: 4.7 ± 0.3; M-MF16:
4.04 ± 0.24; M-MF32: 2.67 ± 0.15; M-MF48: 3.57 ± 0.20.
doi:10.1371/journal.pone.0133878.g004
Fig 5. Mechanical properties of tissue substitutes in the absence of a magnetic field. (a) Elastic
modulus as a function of the amplitude of shear strain in oscillatory tests at an oscillation frequency of 1 Hz.
(b) Shear stress as a function of shear strain obtained under steady-state conditions. Experimental groups:
Ctrl-MF0 and Ctrl-MF16: control (nonmagnetic) tissue substitute without particles, gelled in the absence of a
magnetic field or during application of a 16 kA m-1 field, respectively; Ctrl-NP: control (nonmagnetic) tissue
substitute with nonmagnetic polymer particles; M-MF0: magnetic tissue substitute gelled in the absence of a
magnetic field; M-MF16, M-MF32 and M-MF48: magnetic tissue substitutes gelled during application of a 16
kA m-1, 32 kA m-1 or 48 kA m-1 field, respectively.
doi:10.1371/journal.pone.0133878.g005
Magnetic Field-Responsive Biomaterials
PLOS ONE | DOI:10.1371/journal.pone.0133878 July 24, 2015 10 / 17
With respect to the differences in G0 among different magnetic samples, to analyze the effect
of the concentration of magnetic particles on this value, we calculated the increase in G0 with
respect to the average value in control tissue substitutes without particles (G0control) and nor-
malized these values to the volume fraction of magnetic particles, ϕMagP−OH, and G0control:
G0  G0control
MagPOH  G0control
: ð1Þ
The normalized G0 values approximately overlapped in a single master curve, as shown in
Fig 6.
From the initial linear portion of the curves in Fig 5B we obtained the shear modulus (G) of
the samples as the slope of the curves. As per our procedure for elastic modulus, we analyzed
the effect of magnetic nanoparticles by defining a normalized shear modulus:
G Gcontrol
MagPOH  Gcontrol
: ð2Þ
Fig 6. Normalized elastic modulus of magnetic tissue substitutes plotted as a function of shear strain
amplitude. The elastic modulus, G0, of different magnetic tissue substitutes was normalized to account for the
increase with respect to the elastic modulus of control (nonmagnetic) tissue substitutes without particles (Ctrl-
MF0 to Ctrl-MF48), G0control, per unit volume concentration of magnetic particles, ϕMagP−OH. Experimental
groups: M-MF0: magnetic tissue substitute gelled in the absence of a magnetic field; M-MF16, M-MF32 and
M-MF48: magnetic tissue substitutes gelled during application of a 16 kA m-1, 32 kAm-1 or 48 kAm-1 field,
respectively.
doi:10.1371/journal.pone.0133878.g006
Table 2. Normalized shear modulus (Eq 2) of different magnetic tissue substitutes. Gcontrol = 101 ± 10 Pa represents the mean value for control sam-
ples without particles (Ctrl-MF0 to Ctrl-MF48). Uncertainties were estimated according to theory of error propagation.
Sample namea M-MF0 M-MF16 M-MF32 M-MF48
Normalized shear modulus: (dimensionless) 81 ± 21 49 ± 16 74 ± 22 58 ± 17
a Experimental groups: M-MF0: magnetic tissue substitute gelled in the absence of a magnetic ﬁeld; M-MF16, M-MF32 and M-MF48: magnetic tissue
substitutes gelled during application of a 16 kA m-1, 32 kA m-1 or 48 kA m-1 ﬁeld, respectively.
doi:10.1371/journal.pone.0133878.t002
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Normalized shear modulus data are shown in Table 2. Although normalized shear modulus
values differed among samples, they overlapped when experimental error was taken into
account.
The results in Fig 6 and Table 2 indicate that the higher G0 and G in magnetic tissue substi-
tutes than control samples without particles (Ctrl-MF0 to Ctrl-MF48) were approximately pro-
portional to the volume concentration of magnetic particles. This result is consistent with the
predictions of the classical theory of mechanics of composite materials for a continuous matrix
with spherical inclusions [38]. Note that the higher G0 and G in control samples with nonmag-
netic polymer particles (Ctrl-NP) compared to control samples without particles (Ctrl-MF0 to
Ctrl-MF48) are assumed to be governed by the same theory. In particular, in the special case
where the spherical inclusions are completely rigid and under dilute conditions, and the matrix
material is incompressible, the classical theory of mechanics of composite materials predicts
[38]:
G ¼ ð1þ 2:5ÞGc )
G Gc
Gc
¼ 2:5 ð3Þ
where Gc is the shear modulus of the continuous matrix. The quotient in Eq (3) has the same
structure as the normalized shear modulus deﬁned by Eq (2), where Gcontrol is replaced by Gc.
The value of 2.5 in Eq (3) can thus be interpreted as the theoretical value predicted by the clas-
sical theory of mechanics of composite materials for the normalized shear modulus. It is there-
fore informative to compare this theoretical value of 2.5 against the experimental normalized
shear modulus (Table 2). As observed, the normalized shear modulus of magnetic tissue substi-
tutes was much higher than 2.5, which can be taken as evidence of the much stronger structure
of the continuous matrix of magnetic tissue substitutes compared to control tissue substitutes
without particles. In fact, Eq (3) can be used to calculate the shear modulus of the continuous
matrix of magnetic tissue substitutes (Table 3).
As shown in Table 3, there was a twofold increase in the shear modulus of the continuous
matrix in magnetic tissue substitutes gelled during exposure to a magnetic field, compared to
control tissue substitutes without particles. In magnetic tissue substitutes gelled without a mag-
netic field, the shear modulus of the continuous matrix was even higher, with a threefold
increase compared to control tissue substitutes. These enhancements in the mechanical proper-
ties of the continuous matrix when magnetic particles were included in the formulation of the
engineered tissue substitutes may be due to the changes in the microscopic pattern of the fibrin
network induced by the magnetic particles. The same argument would apply for the enhanced
mechanical properties of control tissue substitutes containing nonmagnetic polymer particles
(Ctrl-NP) compared to control tissue substitutes without particles (Ctrl-MF0 to Ctrl-MF48).
These microstructural changes were evident in samples that were gelled during exposure to a
magnetic field (M-MF16, M-M32, M-MF48), with thick stripes containing closely packed
fibrin fibers aligned in the same direction, as discussed above. Changes in the microscopic pat-
tern of the continuous matrix were not so intense in magnetic tissue substitutes gelled without
Table 3. Shear modulus of the continuousmatrix of magnetic tissue substitutes, as calculated with Eq (3). Note the mean value of the shear modulus
in control samples without particles (Ctrl-MF0 to Ctrl-MF48), Gcontrol = 101 ± 10 Pa. Uncertainties were estimated according to the theory of error propagation.
Sample namea M-MF0 M-MF16 M-MF32 M-MF48
Shear modulus of continuous matrix (Pa) 315 ± 4 211 ± 3 217 ± 3 218 ± 3
a Experimental groups: M-MF0: magnetic tissue substitute gelled in the absence of a magnetic ﬁeld; M-MF16, M-MF32 and M-MF48: magnetic tissue
substitutes gelled during application of a 16 kA m-1, 32 kA m-1 or 48 kA m-1 ﬁeld, respectively.
doi:10.1371/journal.pone.0133878.t003
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application of a magnetic field (M-MF0) or in control tissue substitutes containing nonmag-
netic polymer particles (Ctrl-NP); in both cases the likely reason for the enhanced mechanical
properties is bonding and amalgamation of the fibers to the homogeneously distributed
nanoparticles.
With regard to the influence of magnetic field intensity during the rheological measure-
ments, we observed–as expected–no effect in nonmagnetic control tissue substitutes. In
M-MF0 tissue substitutes, there was little difference in the values of G0 (not shown). For these
samples the effect on shear stress (results not shown) was larger, with a clear tendency of shear
stress to increase with strength of the field applied. For M-MF16, M-MF32 and M-MF48 tissue
substitutes, the magnetic field applied during rheological measurements had a notable effect on
both G0 and shear stress values, as illustrated in Fig 7. We note that as described in the Material
and Methods section, each point in this figure is the average of at least 9 measurements, includ-
ing at least 3 successive cycles of increasing the magnetic field from 0 kA/m to 26 kA/m and
then decreasing it again to 0 kA/m. Since we found no statistically significant differences
among values for the same sample and field strength, we infer that the changes in mechanical
properties after application of a magnetic field are reversible.
As observed, the shape of the G0-vs.-amplitude curves remained similar as the intensity of
the magnetic field increased, despite the fact that G0 increased in average terms together with
the strength of the magnetic field. The same was true for the shear stress-vs.-shear strain
curves. From the linear portion of these curves we obtained the values of shear modulus, and
observed a clear tendency for G to increase with the strength of the magnetic field applied in all
magnetic tissue substitutes (Table 4).
We note that the increases in characteristic mechanical parameters (shear modulus, elastic
modulus, Young modulus, etc.) in samples exposed to increasingly strong magnetic fields is
typical of dispersions of multi-domain magnetic particles in a polymer matrix [30]. This phe-
nomenon is known as the magnetorheological (MR) effect, and we refer to these systems as
MR gels and MR elastomers. In fact, the magnitude of the increases we observed in shear mod-
ulus and elastic modulus with increasingly intense magnetic fields in magnetic tissue substi-
tutes agrees well with previous research on MR elastomers. For example, Jolly et al. [39] found
Fig 7. Effect of a magnetic field on the mechanical properties of magnetic tissue substitutes. Sample M-MF32 is a magnetic tissue substitute gelled
during application of a 32 kA m-1 field. The effect of a magnetic field applied during measurement on the mechanical properties of the tissue substitute is
shown as (a) the elastic modulus as a function of shear strain amplitude, and (b) the initial portion of the shear stress vs. shear strain curves. The intensities
(H) of the magnetic field applied are shown.
doi:10.1371/journal.pone.0133878.g007
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a maximum increase in shear modulus of 30% upon application of a magnetic field in an MR
elastomer consisting of 10 vol% iron particles dispersed in a silicone-based polymer matrix.
More recently, Ge et al. [40] reported a 43% increase in an MR elastomer consisting of approxi-
mately 7 vol% iron particles dispersed in natural rubber. The enhancements reported here
were weaker most probably because of the lower concentration of magnetic particles in the
polymer matrix and the weaker magnetic properties of magnetite (the main constituent of
MagP-OH nanoparticles) compared to iron. Note, for example, that shear modulus increased
by 10% in our magnetic tissue substitutes exposed to a 26 kA/m field compared to no exposure
to a magnetic field during measurement, and elastic modulus showed a slightly large increase.
Finally, it is worth noting that both the magnetic and nonmagnetic tissue substitutes
reported here had values of G and G0 on the same order of magnitude as those obtained in
previous studies of fibrin–agarose scaffolds and oral mucosa tissue substitutes [31,33,41].
Moreover, G and G0 values were within the range of values reported for native human soft tis-
sues (G 5–2500 Pa, G0  10–5000 Pa) [31].
Conclusions
We report a straightforward, versatile method for the preparation of a new type of tissue-
engineered biomaterial characterized by the inclusion of multi-domain magnetic particles in a
biopolymer matrix. Cell viability analyses of oral mucosa fibroblasts showed no significant dif-
ferences in comparison to control (nonmagnetic) tissue substitutes of proven applicability in
tissue regeneration. Thanks to their magnetic behavior, these novel tissue substitutes could be
visualized and followed for in vivo applications by magnetic resonance imaging, and also act as
magnets, attracting functionalized magnetic nanoparticles injected close to them. Although
these advantages are also shared by other magnetic scaffolds described previously, a unique fea-
ture of our magnetic tissue substitutes is that their mechanical properties can be tuned in a con-
trolled, reversible manner by noncontact magnetic force fields. Furthermore, we found that in
the off state (absence of an applied field) the strength of our engineered magnetic tissue substi-
tutes is also affected by the concentration of particles and other technical details, such as the
application of a magnetic field during gelation. This versatility could be exploited in clinical
applications to match the mechanical properties of tissue substitutes to those of natural target
tissues. Several other potential advantages can be envisaged for our magnetic tissue substitutes,
such as their adhesion by magnetic attraction in tissue replacements, which would reduce the
need for surgical sutures in (for example) treatments for gingival recession. To conclude, we
foresee that other similar field-responsive biological tissue substitutes will be generated in the
near future, as applied research contributes to the development of a broad range of promising
novel applications for smart magnetic biomaterials.
Table 4. Effect of the magnetic field applied duringmeasurement on the shear modulus (Pa) of magnetic tissue substitutes. Data in this table corre-
spond to the best linear fit including experimental uncertainties.
Magnetic ﬁeld strength (kA/m) Sample M-F0 a Sample M-MF16 a Sample M-MF32 a Sample M-MF48 a
0 338 ± 3 224 ± 3 225.8 ± 2.2 230 ± 3
9 363 ± 3 237 ± 3 243.6 ± 2.1 237 ± 3
17 369 ± 4 246 ± 3 239.6 ± 1.9 252 ± 3
26 370 ± 4 253 ± 3 245.0 ± 1.9 254 ± 3
a Experimental groups: M-MF0: magnetic tissue substitute gelled in the absence of a magnetic ﬁeld; M-MF16, M-MF32 and M-MF48: magnetic tissue
substitutes gelled during application of a 16 kA m-1, 32 kA m-1 or 48 kA m-1 ﬁeld, respectively.
doi:10.1371/journal.pone.0133878.t004
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Supporting Information
S1 Video. Magnetic tissue substitute attracted by a magnetic field. The novel magnetic field-
responsive tissue substitutes can be moved and manipulated by a noncontact magnetic force
induced by a magnet.
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